BioRestorative Therapies, Inc.
BRTX
$1.57
-$0.04-2.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -183.12% | -121.20% | 13.81% | -34.20% | 77.20% |
| Total Depreciation and Amortization | 15.98% | 17.28% | 14.12% | 17.18% | 21.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 118.75% | 330.26% | -83.93% | 266.84% | -134.27% |
| Change in Net Operating Assets | 1,238.77% | 302.38% | -94.43% | 36.22% | 134.12% |
| Cash from Operations | -36.97% | -36.47% | -27.99% | -15.68% | -3.27% |
| Capital Expenditure | 8.45% | -28.58% | 37.86% | -14.15% | -9.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 464.04% | 293.76% | -81.87% | -496.58% | 79.94% |
| Cash from Investing | 438.12% | 285.27% | -84.18% | -1,284.53% | 78.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.46% | -83.00% | 245.85% | 262.21% | 2,199.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,946.19% | -7,185.26% | -- | -- | -- |
| Cash from Financing | -80.36% | -90.34% | 214.18% | 234.94% | 2,193.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -261.57% | 110.01% | 59.43% | 75.98% | 102.68% |